相关实验视频
Updated: Jun 24, 2025

12:59
Isolation and Th17 Differentiation of Naïve CD4 T Lymphocytes
Published on: September 26, 2013
34.5K
依赖BATF的Th17细胞通过IL-23R通路起作用,促进前列腺腺癌的开始和进展
Sen Liu1, Seleste L Rivero1, Bing Zhang1,2
1Department of Structural & Cellular Biology, Tulane University School of Medicine, New Orleans, LA, USA.
Journal of the National Cancer Institute
|June 4, 2024
概括
转录因子BATF对于Th17细胞分化和前列腺癌的发展至关重要. 针对BATF-IL-23R轴可能提供新的前列腺癌治疗策略.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- 在前列腺癌中T辅助17 (Th17) 细胞的作用尚不清楚.
- 转录因子BATF对于Th17细胞的分化至关重要.
- 缺乏BATF的小鼠缺乏Th17细胞,影响免疫反应.
研究的目的:
- 研究BATF依赖的Th17细胞在前列腺癌中的功能.
- 阐明BATF影响前列腺瘤发展的机制.
- 为了探索前列腺癌中的IL-23-IL-23R信号通路.
主要方法:
- 交叉繁殖BATF淘汰赛小鼠与Pten条件突变小鼠.
- 在基因改造小鼠中分析前列腺形态,瘤发育和细胞过程.
- 评估IL-23-IL-23R信号传递和炎症细胞透.
- 评估抗IL-23p19抗体治疗对前列腺瘤的影响.
- 在人类前列腺瘤中与IL-23A和IL-23R相关的BATFmRNA水平.
主要成果:
- 在Pten突变小鼠中,BATF缺乏减少了前列腺大小,腺癌发育,增殖和血管生成.
- 在BATF淘汰赛小鼠中,IL-23-IL-23R信号传递和炎症细胞透率降低.
- 反IL-23p19治疗降低了前列腺瘤和Pten缺乏小鼠的血管生成.
- 人类前列腺瘤显示了BATF和IL-23/IL-23R表达之间的正相关性.
结论:
- 通过IL-23-IL-23R信号传递,BATF依赖的Th17细胞促进前列腺癌的开始和进展.
- BATF-IL-23R轴代表了前列腺癌的潜在治疗标.
- 针对这一轴可能会导致新的前列腺癌预防和治疗策略.
相关概念视频
T Cell Types and Functions
1.0K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.0K
TGF - β Signaling Pathway
7.3K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.3K
Tumor Immunotherapy
514
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
514

